ANGO: Angiodynamic Inc Company Profile & Statistics

About

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines.

Info & Links

CEO

James C. Clemmer

Headquarters

14 PLAZA DRIVE
LATHAM, NY 12110, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

166

Employees

748

Angiodynamic Inc Statistics

Valuation Measures

Market Capitalization²

375.83M

Enterprise Value

320.82M

Enterprise Value/EBITDA(ttm)

-6.02

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.25

Price to Book(mrq)

1.86

Price to Cash(ytd)

2.10

Profitability

Gross Margin(ttm)

51.82%

Operating Margin(ttm)

-5.11%

Profit Margin(ttm)

-81.09%

Return on Equity(ttm)

-5.86%

Return on Invested Capital(ttm)

-106.13%

Return on Assets(ttm)

-4.17%

Income Statement

Revenue(ttm)

292.73M

Revenue Per Share(ttm)

7.20

Gross Profit(ttm)

151.36M

EBITDA(ttm)³

-53.28M

Net Income Available to Common(ttm)

-243.03M

Diluted EPS(ttm)

-6.09

Share Statistics

Beta (5Y Monthly)

0.68

52-Week Change

36.63%

S&P 500 52-Week Change

27.96%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

40.63M

Dividend Yield

0.00%

Float⁴

38.44M

% Held by Insiders

5.40%

% Held by Institutions

89.43%

Balance Sheet

Total Cash(mrq)

55.01M

Total Cash Per Share(mrq)

1.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.25%

Quick Ratio(mrq)

1.41%

Book Value Per Share(mrq)

4.79

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-19.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ANGO

Angiodynamic Inc

Angiodynamic Inc Profile